Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2]

Dermatology

Volumn 209, Issue 2, 2004, Pages 158-159

  Fargnoli, Maria Concetta ^a   Peris, Ketty ^a   Frascione, Pasquale ^b   Barbati, Rosanna ^c   Anemona, Lucia ^c   Uccini, Stefania ^d   Francesconi, Francesca ^c   Chimenti, Sergio ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Down's syndrome; Hodgkin's disease; Kaposi's sarcoma; Psoriasis

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT ALPHA2A INTERFERON; VITAMIN D DERIVATIVE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOWN SYNDROME; DRUG INDICATION; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KAPOSI SARCOMA; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; TOPICAL TREATMENT; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS EXAMINATION; VIRUS INFECTION;

BIOPSY, NEEDLE; DOWN SYNDROME; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PSORIASIS; RISK ASSESSMENT; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 4444254393     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079604     Document Type: Letter

References (11)

1. Dourmishev A, Miteva L, Mitev V, Pramatarov K, Schwartz RA: Cutaneous aspects of Down syndrome. Pediatr Dermatol 2000;66:420-424.
2. Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami H-O, Olsen JH, Nyren O, Fraumeni JF: Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 2003;163:705-711.
3. Satgè D, Sommelet D, Geneix, Nishi M, Malet P, Vekemans M: A tumor profile in Down syndrome. Am J Hum Genet 1998;78:207-216.
4. Kusumakumary P, Jyothirmayi R: Hodgkin's disease in association with Down syndrome: A case report. Pediatr Hematol Oncol 1996;13:469-471.
5. Park E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G: Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin Immunol 2000;95:62-69.
6. Murphy M, Insoft RM, Pike-Nobile L, Epstein LB: A hypothesis to explain the immune defects in Down syndrome. Prog Clin Biol Res 1995;393:147-167.
7. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE: Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-761.
8. Ensoli B, Stürzl M, Monini P: Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Adv Cancer Res 2001;81:161-200.
9. Ortonne JP: Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 1999;140(suppl 54):1-7.
10. Kirby B, Griffiths CEM: Psoriasis: The future. Br J Dermatol 2001;144:37-43.
11. Fossati S, Boneschi V, Ferrucci S, Brambilla L: Human immunodeficiency virus negative Kaposi sarcoma and lymphoproliferative disorders. Cancer 1999;85:1611-1615.